OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Advances in device-based therapies for cardiorenal syndrome	71
Climate change and cardiovascular risk	33
Elevated C-reactive protein and cardiovascular risk	28
Treatment options to break the cycle of recurrent pericarditis	20
When should the tricuspid valve be repaired during mitral valve repair?	19
Editorial introductions	17
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	15
Artificial intelligence in pediatric cardiology: taking baby steps in the big world of data	14
Review new concepts in pharmacotherapy for peripheral arterial disease	14
Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF	13
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	13
Temporary mechanical circulatory support devices: updates from recent studies	12
Salt restriction for treatment of hypertension – current state and future directions	12
Coronavirus disease 2019, hypertension, and renin–angiotensin–aldosterone system inhibitors	11
Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions	10
Endocan: a new marker of endothelial function	10
Regionalization of congenital cardiac surgical care: what it will take	10
Unanswered questions on coronary artery graft patency and clinical outcomes	10
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?	10
Vascular regenerative cells in cardiometabolic disease	10
Cardiac rehabilitation for coronary artery disease: latest updates	10
Building new cardiac vasculature and myocardium: where are we at?	10
What does complete revascularization mean in 2021? – Definitions, implications, and biases	10
Global interventions in hypertension: new and emerging concepts	10
The role of multimodality imaging in patients with heart failure with reduced and preserved ejection fraction	9

Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	9
Clinical trials of cell therapy for heart failure: recent results warrant continued research	9
Editorial introductions	9
Which lesions are not amenable to tricuspid clipping?	9
Introduction to the coronary artery surgery section	8
A review of the contemporary use of inotropes in patients with heart failure	8
Assessment and management of neonates with unrepaired congenital heart disease	8
A deep dive into the percutaneous mitral valve data	8
The plaque hypothesis: understanding mechanisms of plaque progression and destabilization, and implications for clinical management	8
Current and future transcatheter aortic valve replacement valves	8
Editorial introductions	8
Implementation of remote monitoring strategies to improve chronic heart failure management	8
Ascending aortic intramural hematoma: current concepts	8
Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathy	8
Editorial introductions	8
Secondary hypertension: evaluation and management	8
Editorial introductions	8
Impact of ultrasound enhancing agents on clinical management	7
Mitral annular disjunction and mitral valve prolapse extrapolating adult data to an adolescent cohort?	7
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage	6
Short and long-term complications of hypertensive disorders of pregnancy: lifelong cardiovascular risks we cannot ignore	6
Cardiovascular consequences of vaping	6
Epigenetic regulation of heart failure	6
Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management	6
Genetics of sudden cardiac death	6
Genetics of atrial fibrillation	6
Ablation options for sub-epicardially located ventricular substrates responsible for ventricular tachycardia: where is it all headed?	6
Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease prediction	6
REVIVED BCIS-2: update and key learnings	5
Update on cardiovascular risk in nonalcoholic fatty liver disease	5
Editorial introductions	5
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	5
Team-based strategies to prevent heart failure	5
Epigenetic remodeling in heart failure with preserved ejection fraction	5
Device therapy for heart failure management	5
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy	5
Leaders need to look in the mirror	5
Editorial introduction	5
Selection and management considerations to enhance outcomes in patients supported by left ventricular assist devices	5
Cardiac medications in obstetric patients	5
Treatment of transthyretin cardiac amyloidosis	5
Artificial sweeteners and cardiovascular risk	5
Mobile health technologies in the diagnosis and management of atrial fibrillation	5
Editorial: The year in hyperlipidaemia	5
The current landscape of lipoprotein(a) in calcific aortic valvular disease	5
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	5
Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease	4
Antiplatelet therapy around CABG: the latest evidence	4
Disparity issues in coronary artery surgery	4
Left atrial appendage closure: the journey today and tomorrow	4

Expanding heart transplantation in 2022 and beyond	4
Considerations & challenges of mitral valve repair in females: diagnosis, pathology, and intervention	4
Considerations for specific cardiomyopathies during pregnancy	4
Coronary artery bypass grafting in left ventricular dysfunction: when and how	4
Cryoballoon atrial fibrillation ablation experience in Japan	4
Management of acute pericarditis	4
Exclusion of left atrial appendage: effects beyond thromboembolic prevention	4
Update on cardiogenic shock: from detection to team management	4
Chronic heart failure management in adult patients with congenital heart disease	4
Destination LVAD therapy in the current era of the heart transplant allocation system	4